Skip to main content
Supplement ScienceSupplementScience

Benefits of Devil's Claw

Evidence:Moderate
·

This content is for informational purposes only and does not constitute medical advice. Statements about dietary supplements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Individual results may vary — consult your healthcare provider before starting any supplement. Full disclaimer

Evidence-Based Benefits

  • Lower back pain — Chrubasik et al. (2003, n=197) found devil's claw extract (50mg harpagosides/day) comparably effective to rofecoxib 12.5mg for acute low back pain over 6 weeks
  • Osteoarthritis — a 2014 systematic review (Oltean et al., 14 studies) concluded devil's claw reduces OA pain, with high-dose extract (>60mg harpagosides) showing consistent benefits
  • COX-2 inhibition — harpagosides suppress COX-2 expression and reduce prostaglandin E2 synthesis in vitro and in vivo without significantly affecting COX-1
  • Cytokine modulation — in vitro studies show harpagosides inhibit TNF-alpha, IL-1beta, and IL-6 production by stimulated monocytes
  • Analgesic effect — a 4-month open study (Leblan et al., 2000, n=122) found 61% of patients could reduce or stop NSAID/analgesic use while taking devil's claw

What the Research Says

Devil's Claw is a well-researched herbal anti-inflammatory agent, particularly in Europe. It has received regulatory approval from the German Commission E and ESCOP for its use in degenerative musculoskeletal disorders. A pivotal study by Chrubasik et al. (2003) demonstrated that Devil's Claw was comparable to rofecoxib (Vioxx) in treating acute low back pain, highlighting its efficacy as a potential alternative to nonsteroidal anti-inflammatory drugs (NSAIDs).

A systematic review by Oltean et al. (2014) further corroborated the benefits of Devil's Claw for osteoarthritis (OA), noting positive outcomes across multiple trials. Additionally, an open-label study by Leblan et al. (2000) found that 61% of patients with knee or hip OA were able to reduce their NSAID use while taking Devil's Claw, underscoring its effectiveness as a complementary therapy.

The active compounds in Devil's Claw, known as harpagosides, are responsible for its anti-inflammatory properties. These compounds inhibit cyclooxygenase-2 (COX-2) and various pro-inflammatory cytokines, contributing to its therapeutic effects. Compared to NSAIDs, Devil's Claw generally has a favorable safety profile, though it may cause gastrointestinal side effects in some individuals and should be avoided in cases of peptic ulcer disease.

Overall, Devil's Claw offers a natural alternative for managing musculoskeletal pain and inflammation, supported by robust evidence from clinical trials and systematic reviews.

Related Conditions

Back PainOsteoarthritisInflammation
Full Devil's Claw Guide

References

  1. RCTChrubasik S, Model A, Black A, Pollak S (2003). A randomized double-blind pilot study comparing Doloteffin and Vioxx in the treatment of low back pain. Rheumatology. DOI PubMed
  2. Meta-analysisOltean H, Robbins C, van Tulder MW, et al. (2014). Herbal medicine for low-back pain. Cochrane Database of Systematic Reviews. DOI PubMed
  3. RCTLeblan D, Chantre P, Fournie B (2000). Harpagophytum procumbens in the treatment of knee and hip osteoarthritis: four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine. DOI PubMed
  4. ReviewBrendler T, Gruenwald J, Ulbricht C, Basch E, et al. (2006). Devil's Claw (Harpagophytum procumbens DC): an evidence-based systematic review by the Natural Standard Research Collaboration.. Journal of herbal pharmacotherapy. PubMed
  5. ReviewCrawford C, Boyd C, Paat CF, Meissner K, et al. (2019). Dietary Ingredients as an Alternative Approach for Mitigating Chronic Musculoskeletal Pain: Evidence-Based Recommendations for Practice and Research in the Military.. Pain medicine (Malden, Mass.). DOI PubMed
  6. Puigdellivol J, Comellas Berenger C, Pérez Fernández MÁ, Cowalinsky Millán JM, et al. (2019). Effectiveness of a Dietary Supplement Containing Hydrolyzed Collagen, Chondroitin Sulfate, and Glucosamine in Pain Reduction and Functional Capacity in Osteoarthritis Patients.. Journal of dietary supplements. DOI PubMed